Illumina Inc (ILMN)

190.79
-3.02(-1.56%)
After Hours
191.30
+0.51(+0.27%)
- Real-time Data
  • Volume:
    2,772,114
  • Day's Range:
    183.65 - 194.22
  • 52 wk Range:
    173.45 - 428.00

ILMN Overview

Prev. Close
193.81
Day's Range
183.65-194.22
Revenue
4.69B
Open
193.16
52 wk Range
173.45-428
EPS
-0.129
Volume
2,772,114
Market Cap
30.01B
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
1,537,196
P/E Ratio
-1,530.59
Beta
1.16
1-Year Change
-52.96%
Shares Outstanding
157,300,000
Next Earnings Date
Oct 25, 2022
What is your sentiment on Illumina?
or
Market is currently closed. Voting is open during market hours.

Illumina Inc News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Illumina Inc Analysis

Illumina Inc Company Profile

Illumina Inc Company Profile

Illumina, Inc. is a provider of sequencing- and array-based solutions for genetic and genomic analysis. The Company operates through two segments: Core Illumina and GRAIL. Core Illumina products and services serve customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. GRAIL is a healthcare company focused on early detection of multiple cancers. Its portfolio of integrated sequencing and microarray systems, consumables, and analysis tools is designed for genetic analysis. Customers use its platforms to perform whole genome, de novo, exome and ribonucleic acid (RNA) sequencing, and targeted resequencing of specific gene regions and genes. The Company's BeadArray technology produces arrays that can perform many assays simultaneously. Customers use its array-based genotyping consumables for a range of analyses, including diverse species, disease-related mutations, and genetic characteristics associated with cancer.

Read More

Analyst Price Target

Average259.38 (+35.95% Upside)
High380
Low175
Price190.79
No. of Analysts17
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Analysts 12-Month Price Target

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellStrong Sell
Technical IndicatorsStrong SellStrong SellStrong SellStrong SellStrong Sell
SummaryStrong SellStrong SellStrong SellStrong SellStrong Sell
  • looks like a good buy to throw a little in
    0
    • https://www.bloomberg.com/news/articles/2021-11-29/omicron-tests-biden-s-1-7-billion-plan-to-better-track-variants
      1
      • should i hold?
        0
        • why Illumina corrected after this great earnings?
          0
          • I think for the next EU fine on Grail acquisition
            0
        • IS IT AWEFUL?
          1
          • t
            1
            • should rise on earnings
              1
              • yeah "should"
                0
            • If the trial of Grail's Galeri test with the NHS is a success this stock is going to fly into the stratosphere. Imagine getting an early cancer test with your run of the mill blood draw at the doctors office. Billions in sales per month, millions of lives saved and reduced overall medical expenses. Watching this guy closely.
              4
              • Lol why keep falling tf
                0
                • when the share price go to 550 and above? i am waiting to sell my stock.
                  0